|
US581916A
(en)
|
|
1897-05-04 |
|
Harvester |
|
US4450150A
(en)
|
1973-05-17 |
1984-05-22 |
Arthur D. Little, Inc. |
Biodegradable, implantable drug delivery depots, and method for preparing and using the same
|
|
US4342776A
(en)
|
1979-11-05 |
1982-08-03 |
Merck & Co., Inc. |
4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
|
|
US4399276A
(en)
|
1981-01-09 |
1983-08-16 |
Kabushiki Kaisha Yakult Honsha |
7-Substituted camptothecin derivatives
|
|
US4473692A
(en)
|
1981-09-04 |
1984-09-25 |
Kabushiki Kaisha Yakult Honsha |
Camptothecin derivatives and process for preparing same
|
|
JPS5839685A
(ja)
|
1981-09-04 |
1983-03-08 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体及びその製造法
|
|
JPS58154582A
(ja)
|
1982-03-10 |
1983-09-14 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体およびその製造法
|
|
US4526988A
(en)
|
1983-03-10 |
1985-07-02 |
Eli Lilly And Company |
Difluoro antivirals and intermediate therefor
|
|
JPS6019790A
(ja)
|
1983-07-14 |
1985-01-31 |
Yakult Honsha Co Ltd |
新規なカンプトテシン誘導体
|
|
ATE92499T1
(de)
|
1984-12-04 |
1993-08-15 |
Lilly Co Eli |
Tumorbehandlung bei saeugetieren.
|
|
US5223608A
(en)
|
1987-08-28 |
1993-06-29 |
Eli Lilly And Company |
Process for and intermediates of 2',2'-difluoronucleosides
|
|
US5004758A
(en)
|
1987-12-01 |
1991-04-02 |
Smithkline Beecham Corporation |
Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
|
|
NZ235329A
(en)
|
1989-09-15 |
1992-01-29 |
Res Triangle Inst |
20(s or rs)-camptothecin derivatives and pharmaceutical compositions
|
|
FR2707988B1
(fr)
|
1993-07-21 |
1995-10-13 |
Pf Medicament |
Nouveaux dérivés antimitotiques des alcaloïdes binaires du catharantus rosesus, leur procédé de préparation et les compositions pharmaceutiques les comprenant.
|
|
EP1053752A1
(en)
|
1998-02-10 |
2000-11-22 |
Yoshitomi Pharmaceutical Industries, Ltd. |
Preparations with controlled release
|
|
CA2346866A1
(en)
|
1998-10-16 |
2000-04-27 |
The Government Of The United States Of America As Represented By The Sec Retary Of The Department Of Health And Human Services |
Combination therapy with vip antagonist
|
|
GB2344287A
(en)
|
1998-12-03 |
2000-06-07 |
Ferring Bv |
Controlled release pharmaceutical formulation
|
|
KR100874791B1
(ko)
|
2001-05-29 |
2008-12-18 |
바이엘 쉐링 파마 악티엔게젤샤프트 |
Ｃｄｋ-억제 피리미딘, 그의 제조방법 및 약제로서의 용도
|
|
PH12012502440A1
(en)
|
2001-06-26 |
2013-06-17 |
Amgen Inc |
Antibodies to opgl
|
|
PL369742A1
(en)
|
2001-10-15 |
2005-05-02 |
Gpc Biotech Inc. |
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
|
CA2467633C
(en)
|
2001-12-03 |
2012-03-27 |
Abgenix, Inc. |
Antibody categorization based on binding characteristics
|
|
NZ535232A
(en)
|
2002-02-28 |
2007-05-31 |
Univ Temple |
Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
|
|
US6818663B2
(en)
|
2002-05-17 |
2004-11-16 |
Hoffmann-La Roches |
Diaminothiazoles
|
|
DE60331455D1
(de)
|
2002-10-04 |
2010-04-08 |
Microchips Inc |
Medizinische vorrichtung zur gesteuerten arzneimittelverabreichung sowie herzüberwachung und/oder herzstimulation
|
|
WO2004069137A2
(de)
|
2003-02-07 |
2004-08-19 |
Ge Bayer Silicones Gmbh & Co. Kg |
Verwendung von polyamino- und/oder polyammonium-polysiloxancopolymeren
|
|
WO2004097048A1
(en)
|
2003-04-28 |
2004-11-11 |
Canon Kabushiki Kaisha |
Process for assay of nucleic acid by competitive hybridization using a dna microarray
|
|
NZ580700A
(en)
|
2007-04-19 |
2012-01-12 |
Dong A Pharm Co Ltd |
A biodegradable microsphere composition suitable for the controlled release of glucose controlling peptide and formulation thereof
|
|
US11596642B2
(en)
*
|
2016-05-25 |
2023-03-07 |
Inbiomotion S.L. |
Therapeutic treatment of breast cancer based on c-MAF status
|
|
US20200129473A1
(en)
*
|
2017-07-21 |
2020-04-30 |
Eisai R&D Management Co., Ltd. |
Use of eribulin and cyclin dependent kinase inhibitors in the treatment of cancer
|